Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Nektar Therapeutics (NKTR) hired Dr. Wei Lin as senior vice president of clinical development and head of oncology programs. Previously, he worked at the Genentech unit at Roche (RHHBY), where he was global development leader for cancer immunotherapy in lung and head and neck cancer.
About the Author Reprints
